CHUGAI PHARMACEUTICAL CO., LTD.

CHUGAI PHARMACEUTICAL CO., LTD. logo
🇯🇵Japan
Ownership
Public, Subsidiary
Established
1925-03-10
Employees
7.6K
Market Cap
$83.6B
Website
http://www.chugai-pharm.co.jp

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

First Posted Date
2006-03-20
Last Posted Date
2010-06-03
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
180
Registration Number
NCT00304551
Locations
🇯🇵

Tohoku Region, Tohoku, Japan

🇯🇵

Hokkaido Region, Hokkaido, Japan

🇯🇵

Kyusyu Region, Kyusyu, Japan

and more 5 locations

Trial of Pegasys® in Patients With Chronic Hepatitis C

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-10-28
Last Posted Date
2010-11-17
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
108
Registration Number
NCT00245414
Locations
🇯🇵

Hokkaido Region, Sapporo, Japan

🇯🇵

Chugoku Region, Okayama, Japan

🇯🇵

Kinki Region, Osaka, Japan

and more 3 locations

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

First Posted Date
2005-09-05
Last Posted Date
2009-02-02
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
122
Registration Number
NCT00144482

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

Phase 3
Completed
Conditions
First Posted Date
2005-09-05
Last Posted Date
2009-02-02
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
300
Registration Number
NCT00144469

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

First Posted Date
2005-09-05
Last Posted Date
2009-02-02
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
306
Registration Number
NCT00144508

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

First Posted Date
2005-09-05
Last Posted Date
2009-02-02
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
127
Registration Number
NCT00144521

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

First Posted Date
2005-09-05
Last Posted Date
2009-02-02
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
104
Registration Number
NCT00144495

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-05
Last Posted Date
2013-08-09
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
42
Registration Number
NCT00144586

A New Active Vitamin D, ED-71 for Osteoporosis

First Posted Date
2005-09-05
Last Posted Date
2013-08-09
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
1056
Registration Number
NCT00144456

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-09-05
Last Posted Date
2013-08-09
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
135
Registration Number
NCT00144651
© Copyright 2024. All Rights Reserved by MedPath